EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
Enhancer of zester homolog 2 (EZH2), a histone methyl transferase that mediates H3K27me3 through polycomb repressive complex 2 (PRC2), is overexpressed in ovarian cancer and promotes malignant proliferation. However, the underlying mechanism of maintaining high EZH2 expression remains elusive. Here...
Main Authors: | Ting Liu, Jian Cai, Jing Cai, Zehua Wang, Liqiong Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.608393/full |
Similar Items
-
EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
by: Si Sun, et al.
Published: (2020-05-01) -
Treating human cancer by targeting EZH2
by: Mengfei Xu, et al.
Published: (2025-05-01) -
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
by: Franziska Lea Schümann, et al.
Published: (2021-12-01) -
Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
by: Rasheeda Mohamedali, et al.
Published: (2023-07-01) -
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
by: Haruka Shinohara, et al.
Published: (2022-12-01)